Omar Elashkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Omar Elashkar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Deok Ryong Kim
Department of Biochemistry and Convergence Medical Science, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
5 shared publications - Jin Seok Hwang
Department of Biochemistry and Convergence Medical Sciences and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 527-27, Korea
5 shared publications - Mahmoud Ahmed
Department of Biochemistry and Convergence Medical Sciences and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Gyeongnam, 52727, South Korea
5 shared publications - Trang Huyen Lai
Department of Biochemistry and Convergence Medical Sciences and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, South Korea
5 shared publications - Sahib Zada
Department of Biochemistry and Convergence Medical Sciences and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 527-27, Republic of Korea
3 shared publications - Trang Minh Pham
Department of Biochemistry and Convergence Medical Sciences and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 527-27, Korea
3 shared publications
Latest Publications
- 3 November 2026
- Published by SAGE Publications in Journal of Dental Research
A Quantitative Framework for Characterizing Oral pH Dynamics
Dental caries is a polymicrobial biofilm-based disease whereby acidogenic and aciduric microorganisms within dental plaque generate an acidic milieu resulting in dissolution of enamel and dentin below their critical pH. The relationship of pH over time following exposure to a cariogenic substrate, coined the “Stephan curve,” continues to be a critical determinant in whether a substance is deemed cariogenic. Several caries-associated parameters can be extracted from the data, including minimum pH, time corresponding to the minimum pH, recovery time, time below the critical pH, and area below the critical pH. While wire telemetry devices were developed for continuous recording of plaque pH in vivo, most clinical datasets use the indirect method or strip method due to patient compliance issues, ease of use, and cost limitations. Most of the time, this results in sparse sampling time points. In this work, we demonstrate how sparse datasets lead to underestimation of critical parameters associated with caries risk and can therefore alter the interpretation of the data and conclusions drawn, potentially leading to inaccurate claims. To mitigate this issue, we developed a quantitative framework that harnesses nonlinear mixed effects and fixed effects modeling to better predict these caries-associated pH parameters and show superiority as compared with traditional methods used in prior literature. We conclude by introducing a web-based and publicly available interface (GatorpH) that utilizes our mathematical models. This interface can be readily applied to plaque and saliva pH profiles that are routinely collected in clinical studies 1) assessing the potential relative cariogenicity of dietary items, 2) establishing the efficacy of novel cariostatic agents or biomaterials, or 3) characterizing changes in acidogenicity among patient populations or microbiome studies. Translational researchers, clinicians, and regulatory agencies can therefore utilize GatorpH for the study of oral pH dynamics and for rapid and reliable quantification of critical parameters associated with dental caries.
- 3 November 2026
- Published by SAGE Publications in Journal of Dental Research
A Quantitative Framework for Characterizing Oral pH Dynamics
Dental caries is a polymicrobial biofilm-based disease whereby acidogenic and aciduric microorganisms within dental plaque generate an acidic milieu resulting in dissolution of enamel and dentin below their critical pH. The relationship of pH over time following exposure to a cariogenic substrate, coined the “Stephan curve,” continues to be a critical determinant in whether a substance is deemed cariogenic. Several caries-associated parameters can be extracted from the data, including minimum pH, time corresponding to the minimum pH, recovery time, time below the critical pH, and area below the critical pH. While wire telemetry devices were developed for continuous recording of plaque pH in vivo, most clinical datasets use the indirect method or strip method due to patient compliance issues, ease of use, and cost limitations. Most of the time, this results in sparse sampling time points. In this work, we demonstrate how sparse datasets lead to underestimation of critical parameters associated with caries risk and can therefore alter the interpretation of the data and conclusions drawn, potentially leading to inaccurate claims. To mitigate this issue, we developed a quantitative framework that harnesses nonlinear mixed effects and fixed effects modeling to better predict these caries-associated pH parameters and show superiority as compared with traditional methods used in prior literature. We conclude by introducing a web-based and publicly available interface (GatorpH) that utilizes our mathematical models. This interface can be readily applied to plaque and saliva pH profiles that are routinely collected in clinical studies 1) assessing the potential relative cariogenicity of dietary items, 2) establishing the efficacy of novel cariostatic agents or biomaterials, or 3) characterizing changes in acidogenicity among patient populations or microbiome studies. Translational researchers, clinicians, and regulatory agencies can therefore utilize GatorpH for the study of oral pH dynamics and for rapid and reliable quantification of critical parameters associated with dental caries.
- 18 September 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (6) , 154
Quantitative Characterization of Innate and Adaptive Pharmacology of Allogeneic anti-CD20 Chimeric Antigen Receptor (CAR) Vδ1 γδ T cells using Multiscale Mechanistic Modeling
Gamma Delta (γδ) T Cells are currently being evaluated as a therapeutic alternative to traditional alpha–beta (αβ) T-cells due to
- 18 September 2026
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (6) , 154
Quantitative Characterization of Innate and Adaptive Pharmacology of Allogeneic anti-CD20 Chimeric Antigen Receptor (CAR) Vδ1 γδ T cells using Multiscale Mechanistic Modeling
Gamma Delta (γδ) T Cells are currently being evaluated as a therapeutic alternative to traditional alpha–beta (αβ) T-cells due to
- 18 September 2024
- Published by The R Foundation
PKbioanalysis: Pharmacokinetic Bioanalysis Experiments Design and Exploration
- 18 September 2024
- Published by The R Foundation
PKbioanalysis: Pharmacokinetic Bioanalysis Experiments Design and Exploration
- Open Access
Regulation of TGF-β1-Induced EMT by Autophagy-Dependent Energy Metabolism in Cancer Cells
Metastasis is associated with poor prognosis and is the major cause of death in cancer patients. The epithelial to mesenchymal transition (EMT) is essential for cancer cells to acquire a highly migratory phenotype. Metabolic reprogramming is required to meet the energy demands during this process. Recent studies have indicated that autophagy is involved in EMT, during which cancer cells depend on autophagy activation for survival. However, accumulating evidence indicates that autophagy’s involvement in cancer is context-dependent, acting as either promoter or inhibitor. In this study, we investigated the role of autophagy in supplying energy to support EMT. We induced EMT in Non-small cell lung cancer A549 cells using TGF-1 with and without autophagy inhibition. Suppression of autophagy activity by knocking down of BECN1 or chloroquine (CQ) treatment inhibited mesenchymal protein expression. Interestingly, TGF-1 promoted the transcription of target mRNAs, SNAI1, VIM, and CDH2, regardless of autophagy status. The imbalance between protein and mRNA levels indicated the possibility of autophagy-dependent translational regulation. Since protein synthesis consumes large amounts of energy, it is tightly regulated via various cellular signaling pathways such as AMPK and mTOR. Our investigation showed inhibition of autophagy decreased ATP production from OXPHOS and led to the suppression of mRNA translation by phosphorylation of eukaryotic elongation factor 2 (eEF2). These results suggest that A549 non-small cell lung cancer required autophagy to maintain mitochondrial homeostasis during TGF-1 induced EMT. In conclusion, blocking autophagy decreased energy production and down-regulated proteins synthesis inhibiting TGF-1 induced EMT.Open AccessRegulation of TGF-β1-Induced EMT by Autophagy-Dependent Energy Metabolism in Cancer Cells
Metastasis is associated with poor prognosis and is the major cause of death in cancer patients. The epithelial to mesenchymal transition (EMT) is essential for cancer cells to acquire a highly migratory phenotype. Metabolic reprogramming is required to meet the energy demands during this process. Recent studies have indicated that autophagy is involved in EMT, during which cancer cells depend on autophagy activation for survival. However, accumulating evidence indicates that autophagy’s involvement in cancer is context-dependent, acting as either promoter or inhibitor. In this study, we investigated the role of autophagy in supplying energy to support EMT. We induced EMT in Non-small cell lung cancer A549 cells using TGF-1 with and without autophagy inhibition. Suppression of autophagy activity by knocking down of BECN1 or chloroquine (CQ) treatment inhibited mesenchymal protein expression. Interestingly, TGF-1 promoted the transcription of target mRNAs, SNAI1, VIM, and CDH2, regardless of autophagy status. The imbalance between protein and mRNA levels indicated the possibility of autophagy-dependent translational regulation. Since protein synthesis consumes large amounts of energy, it is tightly regulated via various cellular signaling pathways such as AMPK and mTOR. Our investigation showed inhibition of autophagy decreased ATP production from OXPHOS and led to the suppression of mRNA translation by phosphorylation of eukaryotic elongation factor 2 (eEF2). These results suggest that A549 non-small cell lung cancer required autophagy to maintain mitochondrial homeostasis during TGF-1 induced EMT. In conclusion, blocking autophagy decreased energy production and down-regulated proteins synthesis inhibiting TGF-1 induced EMT. - Open Access
- 14 August 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (8) , 1571
Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration
Intervertebral disc degeneration (IVDD) is a prevalent cause of low back pain. IVDD is characterized by abnormal expression of extracellular matrix components such as collagen and aggrecan. In addition, it results in dysfunctional growth, senescence, and death of intervertebral cells. The biological pathways involved in the development and progression of IVDD are not fully understood. Therefore, a better understanding of the molecular mechanisms underlying IVDD could aid in the development of strategies for prevention and treatment. Autophagy is a cellular process that removes damaged proteins and dysfunctional organelles, and its dysfunction is linked to a variety of diseases, including IVDD and osteoarthritis. In this review, we describe recent research findings on the role of autophagy in IVDD pathogenesis and highlight autophagy-targeting molecules which can be exploited to treat IVDD. Many studies exhibit that autophagy protects against and postpones disc degeneration. Further research is needed to determine whether autophagy is required for cell integrity in intervertebral discs and to establish autophagy as a viable therapeutic target for IVDD.
- 14 August 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (8) , 1571
Open AccessTargeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration
Intervertebral disc degeneration (IVDD) is a prevalent cause of low back pain. IVDD is characterized by abnormal expression of extracellular matrix components such as collagen and aggrecan. In addition, it results in dysfunctional growth, senescence, and death of intervertebral cells. The biological pathways involved in the development and progression of IVDD are not fully understood. Therefore, a better understanding of the molecular mechanisms underlying IVDD could aid in the development of strategies for prevention and treatment. Autophagy is a cellular process that removes damaged proteins and dysfunctional organelles, and its dysfunction is linked to a variety of diseases, including IVDD and osteoarthritis. In this review, we describe recent research findings on the role of autophagy in IVDD pathogenesis and highlight autophagy-targeting molecules which can be exploited to treat IVDD. Many studies exhibit that autophagy protects against and postpones disc degeneration. Further research is needed to determine whether autophagy is required for cell integrity in intervertebral discs and to establish autophagy as a viable therapeutic target for IVDD.
- Open Access
- 26 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0250865
Hierarchical regulation of autophagy during adipocyte differentiation
We previously showed that some adipogenic transcription factors such as CEBPB and PPARG directly and indirectly regulate autophagy gene expression in adipogenesis. The order and effect of these events are undetermined. In this study, we modeled the gene expression, DNA-binding of transcriptional regulators, and histone modifications during adipocyte differentiation and evaluated the effect of the regulators on gene expression in terms of direction and magnitude. Then, we identified the overlap of the transcription factors and co-factors binding sites and targets. Finally, we built a chromatin state model based on the histone marks and studied their relation to the factors’ binding. Adipogenic factors differentially regulated autophagy genes as part of the differentiation program. Co-regulators associated with specific transcription factors and preceded them to the regulatory regions. Transcription factors differed in the binding time and location, and their effect on expression was either localized or long-lasting. Adipogenic factors disproportionately targeted genes coding for autophagy-specific transcription factors. In sum, a hierarchical arrangement between adipogenic transcription factors and co-factors drives the regulation of autophagy during adipocyte differentiation.
- 26 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0250865
Open AccessHierarchical regulation of autophagy during adipocyte differentiation
We previously showed that some adipogenic transcription factors such as CEBPB and PPARG directly and indirectly regulate autophagy gene expression in adipogenesis. The order and effect of these events are undetermined. In this study, we modeled the gene expression, DNA-binding of transcriptional regulators, and histone modifications during adipocyte differentiation and evaluated the effect of the regulators on gene expression in terms of direction and magnitude. Then, we identified the overlap of the transcription factors and co-factors binding sites and targets. Finally, we built a chromatin state model based on the histone marks and studied their relation to the factors’ binding. Adipogenic factors differentially regulated autophagy genes as part of the differentiation program. Co-regulators associated with specific transcription factors and preceded them to the regulatory regions. Transcription factors differed in the binding time and location, and their effect on expression was either localized or long-lasting. Adipogenic factors disproportionately targeted genes coding for autophagy-specific transcription factors. In sum, a hierarchical arrangement between adipogenic transcription factors and co-factors drives the regulation of autophagy during adipocyte differentiation.
- Open Access
- 17 March 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 3052
Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
Raf kinase inhibitory protein (RKIP), also known as a phosphatidylethanolamine-binding protein 1 (PEBP1), functions as a tumor suppressor and regulates several signaling pathways, including ERK and NF-κB. RKIP is severely downregulated in human malignant cancers, indicating a functional association with cancer metastasis and poor prognosis. The transcription regulation of RKIP gene in human cancers is not well understood. In this study, we suggested a possible transcription mechanism for the regulation of RKIP in human cancer cells. We found that Metadherin (MTDH) significantly repressed the transcriptional activity of RKIP gene. An analysis of publicly available datasets showed that the knockdown of MTDH in breast and endometrial cancer cell lines induced the expression RKIP. In addition, the results obtained from qRT-PCR and ChIP analyses showed that MTDH considerably inhibited RKIP expression. In addition, the RKIP transcript levels in MTDH-knockdown or MTDH-overexpressing MCF-7 cells were likely correlated to the protein levels, suggesting that MTDH regulates RKIP expression. In conclusion, we suggest that MTDH is a novel factor that controls the RKIP transcription, which is essential for cancer progression.- 17 March 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 3052
Open AccessTranscriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
Raf kinase inhibitory protein (RKIP), also known as a phosphatidylethanolamine-binding protein 1 (PEBP1), functions as a tumor suppressor and regulates several signaling pathways, including ERK and NF-κB. RKIP is severely downregulated in human malignant cancers, indicating a functional association with cancer metastasis and poor prognosis. The transcription regulation of RKIP gene in human cancers is not well understood. In this study, we suggested a possible transcription mechanism for the regulation of RKIP in human cancer cells. We found that Metadherin (MTDH) significantly repressed the transcriptional activity of RKIP gene. An analysis of publicly available datasets showed that the knockdown of MTDH in breast and endometrial cancer cell lines induced the expression RKIP. In addition, the results obtained from qRT-PCR and ChIP analyses showed that MTDH considerably inhibited RKIP expression. In addition, the RKIP transcript levels in MTDH-knockdown or MTDH-overexpressing MCF-7 cells were likely correlated to the protein levels, suggesting that MTDH regulates RKIP expression. In conclusion, we suggest that MTDH is a novel factor that controls the RKIP transcription, which is essential for cancer progression. - Open Access
Hierarchical Regulation of Autophagy During Adipocyte Differentiation
We previously showed that some adipogenic transcription factors such as CEBPB and PPARG directly and indirectly regulate autophagy gene expression in adipogenesis. The order and the effect of these events are undetermined. In this study, we modeled the gene expression, DNA-binding of transcriptional regulators, and histone modifications during adipocyte differentiation and evaluated the effect of the regulators on gene expression in terms of direction and magnitude. Then, we identified the overlap of the transcription factors and co-factors binding sites and targets. Finally, we built a chromatin states model based on the histone marks and studied their relation with the factors’ binding. Adipogenic factors differentially regulated autophagy genes as part of the differentiation program. Co-regulators associated with specific transcription factors and preceded them to the regulatory regions. Transcription factors differed in the binding time and location, and their effect on expression was either localized or long-lasting. Adipogenic factors disproportionately targeted genes coding for autophagy-specific transcription factors. To sum, a hierarchical arrangement between adipogenic transcription factors and co-factors drives the regulation of autophagy during adipocyte differentiation.
Open AccessHierarchical Regulation of Autophagy During Adipocyte Differentiation
We previously showed that some adipogenic transcription factors such as CEBPB and PPARG directly and indirectly regulate autophagy gene expression in adipogenesis. The order and the effect of these events are undetermined. In this study, we modeled the gene expression, DNA-binding of transcriptional regulators, and histone modifications during adipocyte differentiation and evaluated the effect of the regulators on gene expression in terms of direction and magnitude. Then, we identified the overlap of the transcription factors and co-factors binding sites and targets. Finally, we built a chromatin states model based on the histone marks and studied their relation with the factors’ binding. Adipogenic factors differentially regulated autophagy genes as part of the differentiation program. Co-regulators associated with specific transcription factors and preceded them to the regulatory regions. Transcription factors differed in the binding time and location, and their effect on expression was either localized or long-lasting. Adipogenic factors disproportionately targeted genes coding for autophagy-specific transcription factors. To sum, a hierarchical arrangement between adipogenic transcription factors and co-factors drives the regulation of autophagy during adipocyte differentiation.